Purchase and delivery of oncology medicines for the hospital pharmacy of the Świętokrzyskie Oncology Centre in Kielce

Summary

The tender concerns the purchase and delivery of oncology medicines for the hospital pharmacy of the Świętokrzyskie Oncology Centre in Kielce. The contract is divided into 15 lots covering specific medicines such as apalutamide, doxorubicin, bicalutamide, bleomycin, pegvisomant, topotecan, avapritinib, abemaciclib, palbociclib, enfortumab vedotin, talquetamab, olaparib, pegfilgrastim and capecitabine. The detailed assortment requirements are set out in the price/assortment forms attached to the tender documents. Bidders must submit the offer form, the lot-specific assortment and price form, the European Single Procurement Document, a declaration on the Russia-related exclusion ground, and, for certain lots, product characteristics or a manufacturer’s statement with the required technical data. The successful bidder must later provide criminal record evidence, company registry evidence, a declaration on the capital group, and a valid pharmaceutical wholesale/manufacturing/consignment warehouse authorisation if required. No bid guarantee is required. The bid remains valid until 5 September 2026.